http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-414093-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e08a4083bbee3454fd85e27fd5dbf92a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30 |
| filingDate | 1973-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1981-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-414093-A1 |
| titleOfInvention | PROCEDURE FOR OBTAINING AN ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION |
| abstract | Process for obtaining an anti-inflammatory pharmaceutical composition, in unit dose form, weighing between 0.20 and 5.0 g, preferably between 0.7 and 2.6 g, characterized in that it comprises the steps of first mixing ( a) 1-100 mg of glycyrrhetinic acid and/or at least one active anti-inflammatory derivative thereof and (b) 1-50% by weight of alginic acid and/or at least one non-toxic salt thereof and/or at at least one carboxyalkyl cellulose and/or at least one non-toxic salt thereof; in a second stage mix © 1-30% by weight of at least one non-toxic carbonate and/or bicarbonate and (d) 0-30% by weight of at least one antacid compound, and in a last stage react the mixtures obtained in the first two stages. |
| priorityDate | 1972-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.